Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., Richardson, G. E., Siena, S., Maroto, P., Clemens, M., Bilynskyy, B., Charu, V., Beuzeboc, P., Rader, M., Viniegra, M., Saad, F., Ke, C., Braun, A., Jun, S. Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis f 3 pivotal, randomised, phase 3 trials. European Journal of Cancer 2012; 16: 3082-92